Announcements

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Gynecologic Oncology” listed below:

1. “Cytochrome 4Z1 Expression Is Correlated with Poor Prognosis in Patients with Cervical Cancer”
by Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Ahmed M. M. Youssef, Yahya M. Al-sarayra, Renata A. Al-saraireh, Ghadeer H. Al-muhaisen, Yanal S. Al-mahdy, Ahlam M. Al-Kharabsheh, Seham M. Abufraijeh and Hamzeh Mohammad Alrawashdeh
Curr. Oncol. 2021, 28(5), 3573–3584; https://doi.org/10.3390/curroncol28050306
Available online: https://www.mdpi.com/1718-7729/28/5/306

2. “The Challenge of Return to Work after Breast Cancer: The Role of Family Situation, CANTO Cohort”
by Elsa Caumette, Inès Vaz-Luis, Sandrine Pinto, Julie Havas, Thomas Bovagnet, Garazi Ruiz de Azua, Antonio Di Meglio, Anne-Laure Martin, Sibille Everhard, Paul Cottu et al.
Curr. Oncol. 2021, 28(5), 3866–3875; https://doi.org/10.3390/curroncol28050330
Available online: https://www.mdpi.com/1718-7729/28/5/330

3. “Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema”
by Shirin M. Shallwani, Anna Towers, Anne Newman, Shannon Salvador, Angela Yung, Lucy Gilbert, Walter H. Gotlieb, Xing Zeng and Doneal Thomas
Curr. Oncol. 2021, 28(1), 455–470; https://doi.org/10.3390/curroncol28010048
Available online: https://www.mdpi.com/1718-7729/28/1/48

4. “Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost”
by Ioannis M. Koukourakis, Marianthi Panteliadou, Axiotis G. Giakzidis, Christos Nanos, Ioannis Abatzoglou, Alexandra Giatromanolaki and Michael I. Koukourakis
Curr. Oncol. 2021, 28(5), 3474–3487; https://doi.org/10.3390/curroncol28050300
Available online: https://www.mdpi.com/1718-7729/28/5/300

5. “Omental Macrophagic “Crown-like Structures” Are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer”
by Yu-Ling Liang, Chang-Ni Lin, Hsing-Fen Tsai, Pei-Ying Wu, Sheng-Hsiang Lin, Tse-Ming Hong and Keng-Fu Hsu
Curr. Oncol. 2021, 28(5), 4234–4246; https://doi.org/10.3390/curroncol28050359
Available online: https://www.mdpi.com/1718-7729/28/5/359

6. “A Case of Stevens–Johnson Syndrome in Recurrent Late-Stage Ovarian Cancer Patient after Management of Chronic Pain with Elastomeric Pump”
by Andrej Cokan, Vida Gavrić Lovrec and Iztok Takač
Curr. Oncol. 2021, 28(4), 2928–2932; https://doi.org/10.3390/curroncol28040256
Available online: https://www.mdpi.com/1718-7729/28/4/256

7. “Radiation-Induced Emesis (RIE) in Extended-Field Radiotherapy for Gynecological Malignancies: Dosimetric and Non-Dosimetric Factors”
by Yu-Ming Wang, Yi-Fan Chen, Pei-Yi Lee, Meng-Wei Ho and Eng-Yen Huang
Curr. Oncol. 2021, 28(5), 3602–3609; https://doi.org/10.3390/curroncol28050308
Available online: https://www.mdpi.com/1718-7729/28/5/308

8. “Could the Long-Term Oncological Safety of Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High–Intermediate- and High-Risk Patients? A Multi-Center Turkish Gynecologic Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-End-001)”
by Mehmet Ali Vardar, Ahmet Baris Guzel, Salih Taskin, Mete Gungor, Nejat Ozgul, Coskun Salman, Umran Kucukgoz-Gulec, Ghanim Khatib, Cagatay Taskiran, Ilkkan Dünder et al.
Curr. Oncol. 2021, 28(6), 4328–4340; https://doi.org/10.3390/curroncol28060368
Available online: https://www.mdpi.com/1718-7729/28/6/368

9. “ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group”
by Aristotelis Bamias, Konstantinos Koutsoukos, Nikos Gavalas, Roubini Zakopoulou, Kimon Tzannis, Nikos Dedes, Anna Boulouta, Charalampos Fragkoulis, Eythymios Kostouros, Athanasios Dellis et al.
Curr. Oncol. 2021, 28(6), 4474–4484; https://doi.org/10.3390/curroncol28060380
Available online: https://www.mdpi.com/1718-7729/28/6/380

10. “Clinical Study of Sentinel Lymph Node Detection Using Photodynamic Eye for Abdominal Radical Trachelectomy”
by Naomi Harano, Masaru Sakamoto, Souta Fukushima, Shinnosuke Iwai, Yuki Koike, Shingo Horikawa, Kayo Suzuki, Chikage Narui, Kazuko Matsuoka, Rinko Ozeki et al.
Curr. Oncol. 2021, 28(6), 4709–4720; https://doi.org/10.3390/curroncol28060397
Available online: https://www.mdpi.com/1718-7729/28/6/397

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Head and Neck Oncology” listed below:

1. “Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients”
by Kariem Sharaf, Axel Lechner, Stefan P. Haider, Robert Wiebringhaus, Christoph Walz, Gisela Kranz, Martin Canis, Frank Haubner, Olivier Gires and Philipp Baumeister
Curr. Oncol. 2021, 28(4), 2763–2774; https://doi.org/10.3390/curroncol28040241
Available online: https://www.mdpi.com/1718-7729/28/4/241

2. “Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report”
by Cristina Luongo, Tommaso Porcelli, Francesca Sessa, Maria Angela De Stefano, Francesco Scavuzzo, Vincenzo Damiano, Michele Klain, Claudio Bellevicine, Elide Matano, Giancarlo Troncone et al.
Curr. Oncol. 2021, 28(6), 5401–5407; https://doi.org/10.3390/curroncol28060450
Available online: https://www.mdpi.com/1718-7729/28/6/450

3. “Differential Expression of Non-Coding RNA Signatures in Thyroid Cancer between Two Ethnic Groups”
by Kristiana Rood, Khodeza Begum, Hanmin Wang, Yan C. Wangworawat, Ryan Davis, Celina R. Yamauchi, Mia C. Perez, Alfred A. Simental, Ria T. Laxa, Charles Wang et al.
Curr. Oncol. 2021, 28(5), 3610–3628; https://doi.org/10.3390/curroncol28050309
Available online: https://www.mdpi.com/1718-7729/28/5/309

4. “Clinicopathological Risk Factors for Contralateral Lymph Node Metastases in Intraoral Squamous Cell Carcinoma: A Study of 331 Cases”
by Christian Flörke, Aydin Gülses, Christina-Randi Altmann, Jörg Wiltfang, Henning Wieker and Hendrik Naujokat
Curr. Oncol. 2021, 28(3), 1886–1898; https://doi.org/10.3390/curroncol28030175
Available online: https://www.mdpi.com/1718-7729/28/3/175

5. “Use of Propensity Score Matching to Compare Short Outcomes from Transoral and External Surgical Approaches in Patients with Deep-Lobe Parotid Pleomorphic Adenomas”
by Yue Fan, Shuguang Li, Shuting Yu, Xiaoli Zhu, Xiaohua Shi, Wuyi Li, Zhiqiang Gao and Xingming Chen
Curr. Oncol. 2021, 28(4), 3115–3123; https://doi.org/10.3390/curroncol28040272
Available online: https://www.mdpi.com/1718-7729/28/4/272

6. “Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration”
by Arslan Babar, Neil M. Woody, Ahmed I. Ghanem, Jillian Tsai, Neal E. Dunlap, Matthew Schymick, Howard Y. Liu, Brian B. Burkey, Eric D. Lamarre, Jamie A. Ku et al.
Curr. Oncol. 2021, 28(4), 2409–2419; https://doi.org/10.3390/curroncol28040221
Available online: https://www.mdpi.com/1718-7729/28/4/221

7. “A Rare Coexistence of Paraneoplastic Cerebellar Degeneration: Papillary Thyroid Carcinoma”
by Zeynep Özözen Ayas and Gülgün Uncu
Curr. Oncol. 2021, 28(1), 560–564; https://doi.org/10.3390/curroncol28010055
Available online: https://www.mdpi.com/1718-7729/28/1/55

8. “Occurrence of Arrhythmias in Women with Thyroid Cancer Receiving Suppressive Doses of Levothyroxine”
by Karol Kaziród-Wolski, Aldona Kowalska, Janusz Sielski, Magdalena Biskup-Frużyńska and Grzegorz Piotrowski
Curr. Oncol. 2021, 28(6), 5009–5018; https://doi.org/10.3390/curroncol28060420
Available online: https://www.mdpi.com/1718-7729/28/6/420

9. “WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma”
by Chawalit Ngernsombat, Pongphol Prattapong, Noppadol Larbcharoensub, Krittika Khotthong and Tavan Janvilisri
Curr. Oncol. 2021, 28(4), 2529–2539; https://doi.org/10.3390/curroncol28040230
Available online: https://www.mdpi.com/1718-7729/28/4/230

10. “Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options”
by Anouchka Modesto, Aurore Siegfried, Amelie Lusque, Sébastien Vergez, Jerome Sarini, Laurent Brouchet, Emmanuelle Uro-Coste, Pierre Graff-Cailleaud and Jean Pierre Delord
Curr. Oncol. 2021, 28(3), 1673–1680; https://doi.org/10.3390/curroncol28030156
Available online: https://www.mdpi.com/1718-7729/28/3/156

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Psychosocial Oncology” listed below:

1. “COVID-19 Pandemic Stressors and Psychological Symptoms in Breast Cancer Patients”
by Véronique Massicotte, Hans Ivers and Josée Savard
Curr. Oncol. 2021, 28(1), 294–300; https://doi.org/10.3390/curroncol28010034
Available online: https://www.mdpi.com/1718-7729/28/1/34

2. “Personality Traits and Urinary Symptoms Are Associated with Mental Health Distress in Patients with a Diagnosis of Prostate Cancer”
by Charles Gillis, Gabriela Ilie, Ross Mason, Gregory Bailly, Joseph Lawen, David Bowes, Nikhilesh Patil, Derek Wilke, Robert David Harold Rutledge, David Bell et al.
Curr. Oncol. 2021, 28(4), 2993–3002; https://doi.org/10.3390/curroncol28040262
Available online: https://www.mdpi.com/1718-7729/28/4/262

3. “Examining the Pathoplastic Moderating Role of Education on the Association between Depressive Mood and Self-Rated Health among Cancer Survivors: A Population-Based Study”
by Anao Zhang, Kaipeng Wang and Adam S. DuVall
Curr. Oncol. 2021, 28(5), 4042–4052; https://doi.org/10.3390/curroncol28050343
Available online: https://www.mdpi.com/1718-7729/28/5/343 

4. “Psychosocial Distress in Adult Patients Awaiting Cancer Surgery during the COVID-19 Pandemic”
by David Forner, Sarah Murnaghan, Geoffrey Porter, Ross J. Mason, Paul Hong, S. Mark Taylor, James Bentley, Gregory Hirsch, Christopher W. Noel, Matthew H. Rigby et al.
Curr. Oncol. 2021, 28(3), 1867–1878; https://doi.org/10.3390/curroncol28030173
Available online: https://www.mdpi.com/1718-7729/28/3/173

5. “Treatment Regret, Mental and Physical Health Indicators of Psychosocial Well-Being among Prostate Cancer Survivors”
by Cassidy Bradley, Gabriela Ilie, Cody MacDonald, Lia Massoeurs, Jasmine Dang Cam-Tu Vo and Robert David Harold Rutledge
Curr. Oncol. 2021, 28(5), 3900–3917; https://doi.org/10.3390/curroncol28050333
Available online: https://www.mdpi.com/1718-7729/28/5/333

6. “A Cross-Sectional Survey Exploring the Impact of the COVID-19 Pandemic on the Cancer Care of Adolescents and Young Adults”
by Kaitlyn Howden, Camille Glidden, Razvan G. Romanescu, Andrew Hatala, Ian Scott, Julie Deleemans, Karine Chalifour, Geoff Eaton, Abha A. Gupta, James M. Bolton et al.
Curr. Oncol. 2021, 28(4), 3201–3213; https://doi.org/10.3390/curroncol28040278
Available online: https://www.mdpi.com/1718-7729/28/4/278

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Medical Oncology” listed below:

1. “Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome”
by Sim Vermeulen, Gil Awada, Marleen Keyaerts, Bart Neyns and Hendrik Everaert
Curr. Oncol. 2021, 28(3), 1630–1640; https://doi.org/10.3390/curroncol28030152
Available online: https://www.mdpi.com/1718-7729/28/3/152

2. “The Rethinking Clinical Trials (REaCT) Program. A Canadian-Led Pragmatic Trials Program: Strategies for Integrating Knowledge Users into Trial Design”
by Deanna Saunders, Michelle Liu, Lisa Vandermeer, Mashari Jemaan Alzahrani, Brian Hutton and Mark Clemons
Curr. Oncol. 2021, 28(5), 3959–3977; https://doi.org/10.3390/curroncol28050337
Available online: https://www.mdpi.com/1718-7729/28/5/337

3. “Staging Investigations in Asymptomatic Early Breast Cancer Patients at the Cancer Centre of Southeastern Ontario”
by Dalia Kamel, Veronica Youssef, Wilma M. Hopman and Mihaela Mates
Curr. Oncol. 2021, 28(3), 2190–2198; https://doi.org/10.3390/curroncol28030203
Available online: https://www.mdpi.com/1718-7729/28/3/203

4. “Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice”
by Joyce O’Shaughnessy, Leisha A. Emens, Stephen Y. Chui, Wei Wang, Kenneth Russell, Shih-Wen Lin, Carlos Flores Avile, Patricia Luhn and Andreas Schneeweiss
Curr. Oncol. 2021, 28(4), 2741–2752; https://doi.org/10.3390/curroncol28040239
Available online: https://www.mdpi.com/1718-7729/28/4/239

5. “18F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center”
by Ur Metser, Claudia Ortega, Douglas Hussey, Rosanna Chan, Alejandro Berlin, Antonio Finelli and Patrick Veit-Haibach
Curr. Oncol. 2021, 28(5), 3251–3258; https://doi.org/10.3390/curroncol28050282
Available online: https://www.mdpi.com/1718-7729/28/5/282

6. “The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group”
by Kelvin K. W. Chan, Matthew C. Cheung, Dean A. Regier, Annette Hay, Alexander V. Louie, Winson Y. Cheung, Jean-Eric Tarride, Suji Udayakumar and Nicole Mittmann
Curr. Oncol. 2021, 28(5), 3649–3658; https://doi.org/10.3390/curroncol28050311
Available online: https://www.mdpi.com/1718-7729/28/5/311

7. “Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes”
by Sarah Sharman Moser, Jair Bar, Inna Kan, Keren Ofek, Raanan Cohen, Nikhil Khandelwal, Varda Shalev, Gabriel Chodick and Nava Siegelmann-Danieli
Curr. Oncol. 2021, 28(1), 317–331; https://doi.org/10.3390/curroncol28010036
Available online: https://www.mdpi.com/1718-7729/28/1/36

8. “Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group”
by Wei Fang Dai, Vanessa Arciero, Erica Craig, Brent Fraser, Jessica Arias, Darryl Boehm, Nevzeta Bosnic, Patricia Caetano, Carole Chambers, Barry Jones et al.
Curr. Oncol. 2021, 28(5), 4174–4183; https://doi.org/10.3390/curroncol28050354
Available online: https://www.mdpi.com/1718-7729/28/5/354

9. “Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise”
by Wei Fang Dai, Erica Craig, Brent Fraser, Alex Chambers, Helen Mai, M. Bryson Brown, Craig C. Earle, William K. Evans, Marc Geirnaert, Marianne Taylor et al.
Curr. Oncol. 2021, 28(6), 4645–4654; https://doi.org/10.3390/curroncol28060392
Available online: https://www.mdpi.com/1718-7729/28/6/392

10. “Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in Quebec”
by Jason S. Agulnik, Goulnar Kasymjanova, Carmela Pepe, Manjusha Hurry, Ryan N. Walton, Lama Sakr, Victor Cohen and David Small
Curr. Oncol. 2021, 28(6), 5179–5191; https://doi.org/10.3390/curroncol28060434
Available online: https://www.mdpi.com/1718-7729/28/6/434

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Neuro-Oncology” listed below:

1. “Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation”
by Astrid Ellen Grams, Stephanie Mangesius, Ruth Steiger, Ivan Radovic, Andreas Rietzler, Lisa Maria Walchhofer, Malik Galijašević, Julian Mangesius, Martha Nowosielski, Christian Franz Freyschlag et al.
Curr. Oncol. 2021, 28(6), 5041–5053; https://doi.org/10.3390/curroncol28060424
Available online: https://www.mdpi.com/1718-7729/28/6/424

2. “The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors”
by Angelina Cistaro, Domenico Albano, Pierpaolo Alongi, Riccardo Laudicella, Daniele Antonio Pizzuto, Giuseppe Formica, Cinzia Romagnolo, Federica Stracuzzi, Viviana Frantellizzi, Arnoldo Piccardo et al.
Curr. Oncol. 2021, 28(4), 2481–2495; https://doi.org/10.3390/curroncol28040226
Available online: https://www.mdpi.com/1718-7729/28/4/226

3. “Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis Patients”
by Archya Dasgupta, Jayson Co, Jeff Winter, Barbara-Ann Millar, Normand Laperriere, Derek S. Tsang, Monique van Prooijen, Andrei Damyanovich, Robert Heaton, Catherine Coolens et al.
Curr. Oncol. 2021, 28(1), 549–559; https://doi.org/10.3390/curroncol28010054
Available online: https://www.mdpi.com/1718-7729/28/1/54

4. “The Influence of Gene Aberrations on Survival in Resected IDH Wildtype Glioblastoma Patients: A Single-Institution Study”
by Ondrej Kalita, Zuzana Sporikova, Marian Hajduch, Magdalena Megova Houdova, Rastislav Slavkovsky, Lumir Hrabalek, Matej Halaj, Yvona Klementova, Martin Dolezel, Jiri Drabek et al.
Curr. Oncol. 2021, 28(2), 1280–1293; https://doi.org/10.3390/curroncol28020122
Available online: https://www.mdpi.com/1718-7729/28/2/122

5. “A Contemporary Report of Clinical Outcomes in Patients with Melanoma Brain Metastases”
by William J. Phillips, Tabassom Baghai, Michael Ong, Bryan Lo, Andrea M. Ibrahim, Tyler K.T. Smith and Xinni Song
Curr. Oncol. 2021, 28(1), 428–439; https://doi.org/10.3390/curroncol28010045
Available online: https://www.mdpi.com/1718-7729/28/1/45

6. “Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model”
by Giorgio Russo, Alessandro Stefano, Pierpaolo Alongi, Albert Comelli, Barbara Catalfamo, Cristina Mantarro, Costanza Longo, Roberto Altieri, Francesco Certo, Sebastiano Cosentino et al.
Curr. Oncol. 2021, 28(6), 5318–5331; https://doi.org/10.3390/curroncol28060444
Available online: https://www.mdpi.com/1718-7729/28/6/444

7. “Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma”
by Masazumi Fujii, Masao Kobayakawa, Kiyoshi Saito, Akihiro Inano, Akio Morita, Mitsuhiro Hasegawa, Akitake Mukasa, Takafumi Mitsuhara, Takeo Goto, Shigeru Yamaguchi et al.
Curr. Oncol. 2021, 28(1), 726–739; https://doi.org/10.3390/curroncol28010071
Available online: https://www.mdpi.com/1718-7729/28/1/71

8. “Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy”
by Eric K. Nguyen, Gregory R. Pond, Jeffrey N. Greenspoon, Anthony C. Whitton and Crystal Hann
Curr. Oncol. 2021, 28(5), 3683–3691; https://doi.org/10.3390/curroncol28050314
Available online: https://www.mdpi.com/1718-7729/28/5/314

9. “Salvage Surgical Resection after Linac-Based Stereotactic Radiosurgery for Newly Diagnosed Brain Metastasis”
by Ryosuke Matsuda, Takayuki Morimoto, Tetsuro Tamamoto, Nobuyoshi Inooka, Tomoko Ochi, Toshiteru Miyasaka, Shigeto Hontsu, Kaori Yamaki, Sachiko Miura, Yasuhiro Takeshima et al.
Curr. Oncol. 2021, 28(5), 3683–3691; https://doi.org/10.3390/curroncol28050314
Available online: https://www.mdpi.com/1718-7729/28/5/314

10. “Adult Medulloblastoma Demographic, Tumor and Treatment Impact since 2006: A Canadian University Experience”
by Maria Camila Quinones, Karl Bélanger, Émilie Lemieux Blanchard, Bernard Lemieux, Jean-Paul Bahary, Laura G. Masucci, David Roberge, Cynthia Menard, Carole Lambert, France Berthelet et al.
Curr. Oncol. 2021, 28(4), 3104–3114; https://doi.org/10.3390/curroncol28040271
Available online: https://www.mdpi.com/1718-7729/28/4/271

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Hematology” listed below:

1. “A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma”
by Elif Yilmaz, Arashpreet Chhina, Victor E. Nava and Anita Aggarwal
Curr. Oncol. 2021, 28(6), 5148–5154; https://doi.org/10.3390/curroncol28060431
Available online: https://www.mdpi.com/1718-7729/28/6/431

2. “Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?”
by Mitchell Sabloff, Steven Tisseverasinghe, Mustafa Ege Babadagli and Rajiv Samant
Curr. Oncol. 2021, 28(1), 903–917; https://doi.org/10.3390/curroncol28010089
Available online: https://www.mdpi.com/1718-7729/28/1/89

3. “How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen”
by José Cabeçadas, Victor E. Nava, Joao L. Ascensao and Maria Gomes da Silva
Curr. Oncol. 2021, 28(6), 4611–4633; https://doi.org/10.3390/curroncol28060390
Available online: https://www.mdpi.com/1718-7729/28/6/390

4. “Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase Inhibitor”
by Omar Alkharabsheh, Alhareth Alsayed, Diana M. Morlote and Amitkumar Mehta
Curr. Oncol. 2021, 28(1), 837–841; https://doi.org/10.3390/curroncol28010081
Available online: https://www.mdpi.com/1718-7729/28/1/81 

5. “Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada”
by Jean Lachaine, Catherine Beauchemin, Kimberly Guinan, Philippe Thebault, Andrew Aw, Versha Banerji, Isabelle Fleury and Carolyn Owen
Curr. Oncol. 2021, 28(1), 332–345; https://doi.org/10.3390/curroncol28010037
Available online: https://www.mdpi.com/1718-7729/28/1/37

6. “Spinal Manifestation of Malignant Primary (PLB) and Secondary Bone Lymphoma (SLB)”
by Melanie Barz, Kaywan Aftahy, Insa Janssen, Yu-Mi Ryang, Georg Prokop, Stephanie E. Combs, Philipp J. Jost, Bernhard Meyer and Jens Gempt
Curr. Oncol. 2021, 28(5), 3891–3899; https://doi.org/10.3390/curroncol28050332
Available online: https://www.mdpi.com/1718-7729/28/5/332

7. “The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry”
by Chris Varghese, Tracey Immanuel, Anna Ruskova, Edward Theakston and Maggie L. Kalev-Zylinska
Curr. Oncol. 2021, 28(2), 1544–1557; https://doi.org/10.3390/curroncol28020146
Available online: https://www.mdpi.com/1718-7729/28/2/146

8. “Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma”
by Rami Abdulbaki, Parastou Tizro, Victor E. Nava, Maria Gomes da Silva and João L. Ascensão
Curr. Oncol. 2021, 28(6), 4821–4831; https://doi.org/10.3390/curroncol28060407
Available online: https://www.mdpi.com/1718-7729/28/6/407

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Bone and Soft Tissue Oncology” shown below:

1. “A Case Series of Metastatic Malignant Gastrointestinal Neuroectodermal Tumors and Comprehensive Genomic Profiling Analysis of 20 Cases”
by Taylor Kandler, Eliane Cortez, Lani Clinton, Amanda Hemmerich, Osama Ahmed, Ralph Wong, Taylor Forns, Andrea J. MacNeill, Trevor D. Hamilton, Mohammadali Khorasani et al.
Curr. Oncol. 2022, 29(2), 1279–1297; https://doi.org/10.3390/curroncol29020109
Available online: https://www.mdpi.com/1718-7729/29/2/109 

2. “Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw”
by Veronica Mollica, Giacomo Nuvola, Elisa Tassinari, Maria Concetta Nigro, Andrea Marchetti, Matteo Rosellini, Alessandro Rizzo, Costantino Errani and Francesco Massari
Curr. Oncol. 2022, 29(3), 1709–1722; https://doi.org/10.3390/curroncol29030142
Available online: https://www.mdpi.com/1718-7729/29/3/142 

3. “Minimally Invasive Interventional Procedures for Metastatic Bone Disease: A Comprehensive Review”
by Nicolas Papalexis, Anna Parmeggiani, Giuliano Peta, Paolo Spinnato, Marco Miceli and Giancarlo Facchini
Curr. Oncol. 2022, 29(6), 4155–4177; https://doi.org/10.3390/curroncol29060332
Available online: https://www.mdpi.com/1718-7729/29/6/332

4. “Characteristic of Uterine Rhabdomyosarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor”
by Saya Tamura, Takuma Hayashi, Tomoyuki Ichimura, Nobuo Yaegashi, Kaoru Abiko and Ikuo Konishi
Curr. Oncol. 2022, 29(4), 2350–2363; https://doi.org/10.3390/curroncol29040190
Available online: https://www.mdpi.com/1718-7729/29/4/190

5. “Outcomes of Hip Reconstruction for Metastatic Acetabular Lesions: A Scoping Review of the Literature”
by Sandeep Krishan Nayar, Thomas A. Kostakos, Olga Savvidou, Konstantinos Vlasis and Panayiotis J. Papagelopoulos
Curr. Oncol. 2022, 29(6), 3849–3859; https://doi.org/10.3390/curroncol29060307
Available online: https://www.mdpi.com/1718-7729/29/6/307 

6. “Megaprosthesis for Metastatic Bone Disease—A Comparative Analysis”
by Joachim Thorkildsen, Thale Asp Strøm, Nils Jørgen Strøm, Simen Sellevold and Ole-Jacob Norum
Curr. Oncol. 2022, 29(5), 3460–3471; https://doi.org/10.3390/curroncol29050279
Available online: https://www.mdpi.com/1718-7729/29/5/279

7. “Osseous Union after Mandible Reconstruction with Fibula Free Flap Using Manually Bent Plates vs. Patient-Specific Implants: A Retrospective Analysis of 89 Patients”
by Michael Knitschke, Sophia Sonnabend, Fritz Christian Roller, Jörn Pons-Kühnemann, Daniel Schmermund, Sameh Attia, Philipp Streckbein, Hans-Peter Howaldt and Sebastian Böttger
Curr. Oncol. 2022, 29(5), 3375–3392; https://doi.org/10.3390/curroncol29050274
Available online: https://www.mdpi.com/1718-7729/29/5/274

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Health Economics” shown below:

1. “The Health Economics of Metastatic Hormone-Sensitive and Non-Metastatic Castration-Resistant Prostate Cancer—A Systematic Literature Review with Application to the Canadian Context”
by Ivan Yanev, Jessy Gatete, Jr., Armen G. Aprikian, Jason Robert Guertin and Alice Dragomir
Curr. Oncol. 2022, 29(5), 3393–3424; https://doi.org/10.3390/curroncol29050275
Available online: https://www.mdpi.com/1718-7729/29/5/275

2. “The Pathway for New Cancer Drug Access in Canada”
by Joanna Gotfrit, William Dempster, Johanne Chambers and Paul Wheatley-Price
Curr. Oncol. 2022, 29(2), 455–464; https://doi.org/10.3390/curroncol29020041
Available online: https://www.mdpi.com/1718-7729/29/2/41

3. “Determinants of the Cancer Drug Funding Process in Canada”
by Joanna Gotfrit, Ashley Jackson, John J. W. Shin, David J. Stewart, Ranjeeta Mallick and Paul Wheatley-Price
Curr. Oncol. 2022, 29(3), 1997–2007; https://doi.org/10.3390/curroncol29030162
Available online: https://www.mdpi.com/1718-7729/29/3/162

4. “Health Technology Assessment Process for Oncology Drugs: Impact of CADTH Changes on Public Payer Reimbursement Recommendations”
by Louise Binder, Majd Ghadban, Christina Sit and Kathleen Barnard
Curr. Oncol. 2022, 29(3), 1514–1526; https://doi.org/10.3390/curroncol29030127
Available online: https://www.mdpi.com/1718-7729/29/3/127

5. “Challenges and Adaptations for Providing Smoking Cessation for Patients with Cancer across Canada during the COVID-19 Pandemic”
by Graham W. Warren, Caroline Silverman and Michelle Halligan
Curr. Oncol. 2022, 29(4), 2263–2271; https://doi.org/10.3390/curroncol29040184
Available online: https://www.mdpi.com/1718-7729/29/4/184

6. “Equity-Oriented Healthcare: What It Is and Why We Need It in Oncology”
by Tara C. Horrill, Annette J. Browne and Kelli I. Stajduhar
Curr. Oncol. 2022, 29(1), 186–192; https://doi.org/10.3390/curroncol29010018
Available online: https://www.mdpi.com/1718-7729/29/1/18

7. “Survival in Women with De Novo Metastatic Breast Cancer: A Comparison of Real-World Evidence from a Publicly-Funded Canadian Province and the United States by Insurance Status”
by Marie-France Savard, Elizabeth N. Kornaga, Adriana Matutino Kahn and Sasha Lupichuk
Curr. Oncol. 2022, 29(1), 383–391; https://doi.org/10.3390/curroncol29010034
Available online: https://www.mdpi.com/1718-7729/29/1/34

8. “Rapid Review of Real-World Cost-Effectiveness Analyses of Cancer Interventions in Canada”
by Andrea M. Guggenbickler, Heather K. Barr, Jeffrey S. Hoch and Carolyn S. Dewa
Curr. Oncol. 2022, 29(10), 7285–7304; https://doi.org/10.3390/curroncol29100574
Available online: https://www.mdpi.com/1718-7729/29/10/574

9. “Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021”
by Catherine Lau and George Dranitsaris
Curr. Oncol. 2022, 29(11), 8031–8042; https://doi.org/10.3390/curroncol29110635
Available online: https://www.mdpi.com/1718-7729/29/11/635 

10. “Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group”
by Wei Fang Dai, Claire de Oliveira, Scott Blommaert, Reka E. Pataky, David Tran, Zeb Aurangzeb, Cynthia Kendell, Chris Folkins, Chandy Somayaji, Jeff Dowden et al.
Curr. Oncol. 2022, 29(3), 2046–2063; https://doi.org/10.3390/curroncol29030165
Available online: https://www.mdpi.com/1718-7729/29/3/165

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Childhood, Adolescent and Young Adult Oncology” shown below:

1. “Subsequent Malignant Neoplasm of Bone in Children and Adolescent—Possibility of Multimodal Treatment”
by Anna Raciborska, Katarzyna Bilska, Tomasz Koziński and Carlos Rodriguez-Galindo
Curr. Oncol. 2022, 29(2), 1001–1007; https://doi.org/10.3390/curroncol29020085
Available online: https://www.mdpi.com/1718-7729/29/2/85

2. “The Impact of Exercise on Cardiotoxicity in Pediatric and Adolescent Cancer Survivors: A Scoping Review”
by Stephanie J. Kendall, Jodi E. Langley, Mohsen Aghdam, Bruce N. Crooks, Nicholas Giacomantonio, Stefan Heinze-Milne, Will J. Johnston, Melanie R. Keats, Sharon L. Mulvagh and Scott A. Grandy
Curr. Oncol. 2022, 29(9), 6350–6363; https://doi.org/10.3390/curroncol29090500
Available online: https://www.mdpi.com/1718-7729/29/9/500

3. “Recruiting Adolescent and Young Adult Cancer Survivors for Patient-Reported Outcome Research: Experiences and Sample Characteristics of the SURVAYA Study”
by Carla Vlooswijk, Lonneke V. van de Poll-Franse, Silvie H. M. Janssen, Esther Derksen, Milou J. P. Reuvers, Rhodé Bijlsma, Suzanne E. J. Kaal, Jan Martijn Kerst, Jacqueline M. Tromp, Monique E. M. M. Bos et al.
Curr. Oncol. 2022, 29(8), 5407–5425; https://doi.org/10.3390/curroncol29080428
Available online: https://www.mdpi.com/1718-7729/29/8/428

4. “The Transformation of Adolescent and Young Adult Oncological and Supportive Care in Canada: A Mixed Methods Study”
by Jonathan Avery, Emily Wong, Christine Harris, Stacy Chapman, Serena Uppal, Shaayini Shanawaz, Annemarie Edwards, Laura Burnett, Tushar Vora and Abha A. Gupta
Curr. Oncol. 2022, 29(7), 5126–5138; https://doi.org/10.3390/curroncol29070406
Available online: https://www.mdpi.com/1718-7729/29/7/406

5. “Reflections of Moral Suffering, Resilience, and Wisdom of Pediatric Oncology Social Workers during the COVID-19 Pandemic”
by Barbara Jones, Nancy Cincotta, Wendy Pelletier, Abigail Fry and Lori Wiener
Curr. Oncol. 2022, 29(9), 6177–6185; https://doi.org/10.3390/curroncol29090485
Available online: https://www.mdpi.com/1718-7729/29/9/485

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Dermato-Oncology” shown below:

1. “Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile”
by Alessandra Buja, Massimo Rugge, Giuseppe De Luca, Emanuela Bovo, Manuel Zorzi, Chiara De Toni, Claudia Cozzolino, Antonella Vecchiato, Paolo Del Fiore, Romina Spina et al.
Curr. Oncol. 2022, 29(3), 2165–2173; https://doi.org/10.3390/curroncol29030175
Available online: https://www.mdpi.com/1718-7729/29/3/175

2. “Assessing Choroidal Nevi, Melanomas and Indeterminate Melanocytic Lesions Using Multimodal Imaging—A Retrospective Chart Review”
by Fredy Geiger, Sadiq Said, Anahita Bajka, Mario Damiano Toro, Maximilian Robert Justus Wiest, Marc Stahel, Daniel Barthelmes and Sandrine Anne Zweifel
Curr. Oncol. 2022, 29(2), 1018–1028; https://doi.org/10.3390/curroncol29020087
Available online: https://www.mdpi.com/1718-7729/29/2/87

3. “Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019)”
by Giulia Bertino, Tobian Muir, Joy Odili, Ales Groselj, Roberto Marconato, Pietro Curatolo, Erika Kis, Camilla Kjaer Lonkvist, James Clover, Pietro Quaglino et al.
Curr. Oncol. 2022, 29(8), 5324–5337; https://doi.org/10.3390/curroncol29080423
Available online: https://www.mdpi.com/1718-7729/29/8/423

4. “Antibody-Negative Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS) in a Patient with Follicular Lymphoma Accompanied by an Excess of Peripheral Blood CD8+ Lymphocytes”
by Thilo Gambichler, Yi-Pei Lee, Ilske Oschlies, Christina H. Scheel, Wolfram Klapper, Nico Nowack, Martin Doerler, Markus Stücker, Nasreddin Abolmaali and Laura Susok
Curr. Oncol. 2022, 29(4), 2395–2405; https://doi.org/10.3390/curroncol29040194
Available online: https://www.mdpi.com/1718-7729/29/4/194

5. “Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab—Real-World Experience in the Global SARS-CoV-2 Pandemic”
by Marta Pabianek, Aleksandra Lesiak, Dariusz Nejc, Łukasz Kuncman, Joanna Narbutt, Małgorzata Skibińska and Magdalena Ciążyńska
Curr. Oncol. 2022, 29(10), 7794–7801; https://doi.org/10.3390/curroncol29100616
Available online: https://www.mdpi.com/1718-7729/29/10/616

6. “An Epidemiological Update on Indoor Tanning and the Risk of Skin Cancers”
by Clio Dessinioti and Alexander J. Stratigos
Curr. Oncol. 2022, 29(11), 8886–8903; https://doi.org/10.3390/curroncol29110699
Available online: https://www.mdpi.com/1718-7729/29/11/699

7. “Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis”
by Lise Mayrin Økland Thunestvedt, Lars Helgeland, Ingeborg Margrethe Bachmann, Åsa Karlsdottir, Torjan Magne Haslerud and Håkon Reikvam
Curr. Oncol. 2022, 29(4), 2193–2198; https://doi.org/10.3390/curroncol29040178
Available online: https://www.mdpi.com/1718-7729/29/4/178

8. “Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement”
by Thomas Breakell, Heidi Waibel, Stefan Schliep, Barbara Ferstl, Michael Erdmann, Carola Berking and Markus V. Heppt
Curr. Oncol. 2022, 29(5), 2909–2919; https://doi.org/10.3390/curroncol29050237
Available online: https://www.mdpi.com/1718-7729/29/5/237